FTC Rules Impax $112mn Pay-For-Delay Deal With Endo Was Illegal

Delayed
The FTC Claims That Impax Illegally Delayed US Market Entry with Generic Opana ER In Return For A Payment • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin